Why antidepressants often fail
January 14th, 2010 - 4:11 pm ICT by ANIWashington, Jan 14 (ANI): A new study from researchers at Columbia University Medical Center has explained why antidepressants fail to relieve symptoms of depression for 50 percent of patients.
The study in a mouse model was led by Rene Hen, professor of pharmacology in the Departments of Psychiatry and Neuroscience at Columbia University, and a researcher the New York State Psychiatric Institute.
Most antidepressants - including the popular SSRIs - work by increasing the amount of serotonin made by cells — called raphe neurons — deep in the middle of the brain. Serotonin relieves symptoms of depression when it is shipped to other brain regions.
However, too many serotonin receptors of the 1A type on the raphe neurons sets up a negative feedback loop that reduces the production of serotonin, the researchers discovered.
“The more antidepressants try to increase serotonin production, the less serotonin the neurons actually produce, and behavior in mice does not change,” Hen said.
The researchers measured the effect of antidepressants with a commonly used behavioral test that measures the boldness in mice when retrieving food from bright open areas.
Mice on antidepressants usually become more daring, but the drugs had no such effect on mice with surplus serotonin receptors.
Recent genetic and imaging studies of depressed patients have suggested that high receptor numbers of the 1A type in the raphe neurons are associated with treatment failure.
Until now, no direct test of the association could be performed because the number of receptors in the raphe neurons could not be altered without changing the number of receptors in other parts of the brain.
Using new techniques in genetic engineering, Hen created a strain of mouse that can be programmed to produce high or low levels of serotonin receptors of the 1A type only in the raphe neuron.
The levels present in the mice mimicked the levels found in people who are resistant to antidepressant treatment.
“By simply tweaking the number of receptors down, we were able to transform a non-responder into a responder,” Hen said.
The study appears in the January 15 issue of the journal Neuron. (ANI)
- New mouse model to probe how antidepressants work - Feb 19, 2011
- New target for antidepressants revealed - Jun 01, 2010
- Genetically defective mice to help understand human depression - Jun 30, 2010
- Antidepressant use linked to thicker arteries - Apr 03, 2011
- Why some people become depressed when they are stressed - Jan 27, 2011
- Gene therapy to brain may treat major depression - Oct 21, 2010
- Blood test to tell whether anti-depressants work - Dec 16, 2011
- Indian-origin scientist's find may lead to cognition, mood-improving drugs - Apr 04, 2011
- Serotonin may play role in autism - Feb 25, 2011
- Brain chemical that regulates mood may have anti-diabetic properties - Nov 14, 2010
- How Prozac alters brain plasticity - Mar 16, 2011
- Delating a gene works up smarter brain - Mar 11, 2012
- Brain chemical that regulates mood may have anti-diabetic properties too - Nov 11, 2010
- Neurological protein may hold the key to novel depression treatments - Nov 30, 2010
- Anti-depressants doing more harm than good: Study - Apr 25, 2012
Tags: antidepressants, boldness, brain regions, columbia university medical, depressed patients, genetic engineering, mice, mouse model, negative feedback loop, neuron, neuroscience, new york state, new york state psychiatric institute, open areas, parts of the brain, pharmacology, serotonin receptors, symptoms of depression, treatment failure, university medical center